Grufity logoGrufity logo

AMED

91.50USD+0.52(+0.57%)Market Closed

Amedisys Inc

Market Summary

USD91.50+0.52Market Closed
0.57%

AMED Alerts

AMED Stock Price

RSI Chart

Valuation

Market Cap

3.2B

Price/Earnings

26.22

Price/Sales

1.43

Price/Cashflow

32.5

MarketCap/EBT

19.13

Price/Sales

Profitability

EBT Margin

7.47%

Return on Equity

11.31%

Return on Assets

6.1%

Fundamentals

Revenue

Revenue (TTM)

2.2B

Revenue Y/Y

0.82%

Revenue Q/Q

0.02%

Earnings

Earnings (TTM)

120.9M

Earnings Y/Y

-43.03%

Earnings Q/Q

-13.31%

Price Action

52 Week Range

83.01179.91
(Low)(High)

Last 7 days

0.5%

Last 30 days

2.0%

Last 90 days

-21.3%

Trailing 12 Months

-35.4%

Financial Health

Current Ratio

1.06

Debt/Equity

0.43

Debt/Cashflow

0.21

Investor Care

Buy Backs (1Y)

0.34%

Diluted EPS (TTM)

3.71

Peers (Alternatives to Amedisys)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
64.2B
59.8B
11.79% 3.75%
9.86
1.07
3.14% -18.15%
20.3B
15.3B
7.88% -16.34%
10.19
1.29
-7.83% -36.44%
16.9B
10.3B
7.10% -0.58%
13.7
1.64
-6.81% -43.45%
MID-CAP
8.6B
13.2B
14.34% 6.50%
11.12
0.66
6.21% -30.27%
6.9B
2.1B
7.44% 10.27%
24.88
3.22
-0.11% -14.81%
5.5B
5.5B
1.72% 10.13%
11.91
1.05
68.51% 117.01%
5.2B
2.3B
-2.62% 40.74%
54.18
2.25
7.63% -28.34%
5.0B
2.9B
3.98% 23.47%
23.43
1.72
13.49% 10.78%
4.9B
408.1M
17.54% -43.94%
-9.19
11.99
26.10% -44.06%
3.2B
2.2B
1.98% -35.39%
26.22
1.43
0.68% -45.06%
SMALL-CAP
1.7B
928.7M
4.41% 26.82%
38.16
1.87
11.11% 9.39%
1.6B
500.7M
0.59% 17.88%
18.77
3.24
-11.66% 1451.89%
1.1B
1.4B
13.21% -28.42%
47.05
0.81
6.94% -77.50%
954.4M
1.1B
-1.33% -5.47%
30.82
0.86
8.39% -81.41%
248.1M
133.3M
12.63% 41.76%
28.83
1.96
14.60% -22.15%

Financials for Amedisys

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue0.2%2,2212,2162,2222,2142,206
  S&GA Expenses1.7%736724711702
Earnings Before Taxes-11.3%166187256280295
Net Income-13.8%121140191209220
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-0.9%1,9822,0011,9081,8571,938
  Current Assets-1.5%389395392357433
    Cash Equivalents18.6%32276843124
  Net PPE-3.4%1718171820
  Goodwill-0.3%1,2851,2901,2051,1961,188
Liabilities-5.1%913962888881989
  Current Liabilities-14.1%367427380374454
  Long Term Debt0.2%456455442445448
    LT Debt, Current0.8%1313121313
    LT Debt, Non Current0.2%443442430432435
Shareholder's Equity8.5%1,070986967931905
  Retained Earnings3.7%726700671639605
  Additional Paid-In Capital0.9%743737728721-
Accumulated Depreciation2.1%1021009997100
Shares Outstanding0.1%3232333333
Minority Interest1.0%5453544544
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-43.6%98173184189250
  Share Based Compensation-3.9%2223242425
Cashflow From Investing71.6%-104.29-367.81-296.13-281.61-271.50
Cashflow From Financing-159.6%-90.031511055535
  Buy Backs-25.0%32432710085

Risks

What is the probability of a big loss on AMED?

73.1%


Probability that Amedisys stock will be more than 20% underwater in next one year

26.9%


Probability that Amedisys stock will be more than 30% underwater in next one year.

23.9%


Probability that Amedisys stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does AMED drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Amedisys was unfortunately bought at previous high price.

Returns

Cumulative Returns on AMED

23.7%


10-Year Cumulative Returns

12.3%


7-Year Cumulative Returns

11.6%


5-Year Cumulative Returns

-17.8%


3-Year Cumulative Returns

What are the long-term rolling returns for AMED?

FIve years rolling returns for Amedisys.

Which funds bought or sold AMED recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
898,000
898,000
0.01%
2022-11-22
Capital Impact Advisors, LLC
REDUCED
-17.26
-249,000
563,000
0.56%
2022-11-22
Seaport Global Advisors, LLC
REDUCED
-5.86
-28,000
185,000
0.75%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-5.09
-569,000
3,942,000
0.01%
2022-11-16
Front Row Advisors LLC
NEW
-
3,000
3,000
-%
2022-11-16
Neo Ivy Capital Management
SOLD OFF
-100
-44,000
-
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
REDUCED
-8.1
-104,000
572,000
-%
2022-11-16
Retirement Systems of Alabama
REDUCED
-0.47
-812,000
8,892,000
0.04%
2022-11-15
Almanack Investment Partners, LLC.
NEW
-
3,000
3,000
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
ADDED
1.31
-119,000
1,650,000
0.01%

1–10 of 45

Latest Funds Activity

Are funds buying AMED calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own AMED

Amedisys News

Benzinga

Amedisys to Present at Bank of America Securities Home Care Conference - Amedisys (NASDAQ:AMED).2 days ago

Seeking Alpha

Marketscreener.com

Yahoo Finance

AMED Fair Value

Recent SEC filings of Amedisys

View All Filings
Date Filed Form Type Document
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 22, 2022
8-K
Current Report
Nov 18, 2022
8-K
Current Report
Nov 17, 2022
8-K
Current Report
Oct 27, 2022
10-Q
Quarterly Report
Oct 26, 2022
8-K
Current Report
Oct 24, 2022
4
Insider Trading
Oct 21, 2022
8-K
Current Report
Oct 19, 2022
3
Insider Trading

Latest Insider Trading transactions for AMED

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-21
Ginn Scott G
ACQUIRED
-
-
23,109
EVP, CFO & Acting COO
2022-11-21
Muscato Nick
ACQUIRED
-
-
11,555
Chief Strategy Officer
2022-10-20
Holton Adam Y
ACQUIRED
-
-
5,181
Chief People Officer
2022-07-25
Muscato Nick
SOLD (Taxes)
-92,161.4
128.18
-719
Chief Strategy Officer
2022-07-25
Bohnert Denise M.
SOLD (Taxes)
-69,089
128.18
-539
Chief Compliance Officer
2022-06-23
Bohnert Denise M.
SOLD
-64,055
115
-557
Chief Compliance Officer
2022-06-10
Bohnert Denise M.
SOLD (Taxes)
-55,966.6
120.1
-466
Chief Compliance Officer
2022-06-09
Rideout Jeffrey A
ACQUIRED
-
-
1,304
-
2022-06-09
Kline Teresa L.
ACQUIRED
-
-
1,304
-
2022-06-09
Klapstein Julie D
ACQUIRED
-
-
1,304
-

1–10 of 50

Christopher T. Gerard
21000
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

AMED Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net service revenue$ 557,988$ 553,485$ 1,661,135$ 1,654,795
Other operating income0(4)013,300
Cost of service, excluding depreciation and amortization322,227310,294943,258916,188
General and administrative expenses:    
Salaries and benefits125,550119,373376,788349,533
Non-cash compensation3,4954,39715,99017,860
Other59,29955,158167,851158,995
Depreciation and amortization5,4777,48719,70521,763
Investment impairment3,00903,0090
Operating expenses519,057496,7091,526,6011,464,339
Operating income38,93156,772134,534203,756
Other income (expense):    
Interest income59010849
Interest expense(4,963)(2,730)(16,447)(6,734)
Equity in earnings (loss) from equity method investments3021,444(442)3,932
Gain on equity method investments00031,092
Miscellaneous, net4914901,1551,253
Total other (expense) income, net(4,111)(796)(15,626)29,592
Income before income taxes34,82055,976118,908233,348
Income tax expense(9,417)(10,731)(32,755)(57,192)
Net income25,40345,24586,153176,156
Net loss (income) attributable to noncontrolling interests239(239)739(1,131)
Net income attributable to Amedisys, Inc.$ 25,642$ 45,006$ 86,892$ 175,025
Basic earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, basic (usd per share)$ 0.79$ 1.38$ 2.67$ 5.36
Weighted average shares outstanding, basic (shares)32,48232,60732,51932,658
Diluted earnings per common share:    
Net income attributable to Amedisys, Inc. common stockholders, diluted (usd per share)$ 0.79$ 1.37$ 2.66$ 5.30
Weighted average shares outstanding, diluted (shares)32,61632,89932,68033,021

AMED Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 17,956$ 42,694
Restricted cash13,5043,075
Patient accounts receivable302,470274,961
Prepaid expenses17,01110,356
Other current assets37,83925,598
Total current assets388,780356,684
Property and equipment, net of accumulated depreciation of $102,407 and $96,93717,24818,435
Operating lease right of use assets105,843101,257
Goodwill1,285,4551,196,090
Intangible assets, net of accumulated amortization of $11,891 and $19,900103,678111,190
Deferred income tax assets0289
Other assets81,12373,023
Total assets1,982,1271,856,968
Current liabilities:  
Accounts payable45,52738,217
Payroll and employee benefits145,073141,001
Accrued expenses130,100150,836
Current portion of long-term obligations12,62812,995
Current portion of operating lease liabilities33,87231,233
Total current liabilities367,200374,282
Long-term obligations, less current portion443,431432,075
Operating lease liabilities, less current portion72,03069,309
Deferred income tax liabilities15,9830
Other long-term obligations13,8734,979
Total liabilities912,517880,645
Commitments and Contingencies—Note 6 
Equity:  
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding00
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,852,059 and 37,674,868 shares issued; and 32,479,475 and 32,509,969 shares outstanding3838
Additional paid-in capital750,914728,118
Treasury stock, at cost 5,372,584 and 5,164,899 shares of common stock(461,168)(435,868)
Retained earnings725,955639,063
Total Amedisys, Inc. stockholders’ equity1,015,739931,351
Noncontrolling interests53,87144,972
Total equity1,069,610976,323
Total liabilities and equity$ 1,982,127$ 1,856,968